ワルファリンＫ細粒０．２％「ＮＳ」
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00682 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 51 |
| 日本商品名（例） | ワルファリンＫ細粒０．２％「ＮＳ」 |
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | thrombotic disease | 99% | DL |
| 2 | heparin cofactor 2 deficiency | 99% | DL |
| 3 | factor 5 excess with spontaneous thrombosis | 99% | DL |
| 4 | antithrombin deficiency type 2 | 99% | DL |
| 5 | thrombophilia | 99% | DL |
| 6 | rheumatoid arthritis | 99% | DL |
| 7 | breast fibrocystic disease | 99% | DL |
| 8 | benign mammary dysplasia | 99% | DL |
| 9 | apocrine adenosis of breast | 98% | DL |
| 10 | blunt duct adenosis of breast | 98% | DL |
| 11 | migraine disorder | 98% | DL |
| 12 | migraine with brainstem aura | 98% | DL |
| 13 | brachydactyly-syndactyly syndrome | 98% | DL |
| 14 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | 98% | DL |
| 15 | fat necrosis of breast | 98% | DL |
| 16 | breast abscess | 98% | DL |
| 17 | migraine with or without aura, susceptibility to | 98% | DL |
| 18 | myocardial infarction | 98% | DL |
| 19 | posterolateral myocardial infarction | 98% | DL |
| 20 | posteroinferior myocardial infarction | 98% | DL |
| 21 | coronary thrombosis | 98% | DL |
| 22 | lactation disease | 98% | DL |
| 23 | septal myocardial infarction | 98% | DL |
| 24 | breast adenosis | 97% | DL |
| 25 | congenital coronary artery anomaly | 97% | DL |
| 26 | vein disease | 97% | DL |
| 27 | lateral sinus thrombosis | 97% | DL |
| 28 | cavernous sinus thrombosis | 97% | DL |
| 29 | intracranial embolism | 95% | DL |
| 30 | atrophoderma vermiculata | 95% | DL |
| 31 | stroke disorder | 95% | DL |
| 32 | coronary stenosis | 94% | DL |
| 33 | amenorrhea (disease) | 94% | DL |
| 34 | sagittal sinus thrombosis | 94% | DL |
| 35 | ulerythema ophryogenesis | 94% | DL |
| 36 | Prinzmetal angina | 94% | DL |
| 37 | myositis fibrosa | 93% | DL |
| 38 | idiopathic granulomatous myositis | 93% | DL |
| 39 | fibrocartilaginous embolism | 93% | DL |
| 40 | venous thromboembolism | 93% | DL |
| 41 | tendinitis | 93% | DL |
| 42 | myocardial infarction (disease) | 92% | DL |
| 43 | angiodysplasia | 92% | DL |
| 44 | non-inflammatory vasculopathy | 92% | DL |
| 45 | female breast carcinoma | 92% | DL |
| 46 | congenital renal artery stenosis | 91% | DL |
| 47 | pediatric systemic lupus erythematosus | 91% | DL |
| 48 | hemoglobinopathy | 90% | DL |
| 49 | osteoarthritis | 90% | DL |
| 50 | gout | 90% | DL |
（上位50件を表示。全51件の予測があります）
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。